BHC BHC ボシュ・ヘルス・カンパニ―ズ

Equities in Toronto finished Monday, the penultimate session of January, on the downside, as losses in health-care cast a shadow over markets. The TSX fell 142.37 points to close Monday at 20,572.11. The Canadian dollar let go of 0.45 cents at 74.70 cents U.S. Health-care took the worst pounding, as Bausch Health lost 75 cents, or 6.7%, to $10.40, while Tilray handed over 14 cents, or 3.3%, to $4.14. In energy, Peyto Exploration wilted 79 cents, or 6.1%, to $12.23, while Nuvista dipped 52 cents, or 4.4%, to $11.19. Tech stocks also felt around for the bruises, mostly Quarterhill, down 10 cents, or 5.2%, to $1.84, while Shopify suffered $3.15, or 4.7%, to $63.51. Industrial stocks such as Ritchie Bros Auctioneers, progressed $1.22, or 1.6%, to $79.67. Brookfield Business Partners gained 31 cents, or 1.1%, to $27.88. Communications also made gains, primarily BCE, up 52 cents to $62.84 while Cogeco Communications added 47 cents to $69.26. Among individual stocks, Fairfax Financial Holdings climbed $15.96, or 1.9%, to $867.26 after BMO raised the insurer''s rating to "outperform" from "market perform".

On CNBC’s "Mad Money Lightning Round," Jim Cramer said L3Harris Technologies Inc (NYSE: LHX ) is still a buy. "There’s so many people betting against it, and they’re wrong," he added. Analysts have a consensus Neutral rating on LHX, according to Benzinga analyst ratings data. When asked about Bausch Health Companies Inc (NYSE: BHC ), he said, "We’ve got that on what I would regard as being a retainer basis. We simply don’t know … Full story available on Benzinga.com

Bausch Health Companies Inc. (NYSE:BHC) closed Thursday at $7.77 per share, down from $7.89 a day earlier. While Bausch Health Companies Inc. has underperformed by -1.52%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BHC fell by -70.79%, with highs and lows ranging from $26.88 to […]

Canada''s main stock index rose for a seventh consecutive session on Monday, lifted by energy, financial and technology stocks, while traders looked ahead to a week packed with key economic data including consumer price inflation. The TSX progressed 53.16 points to break for lunch at 20,413.26. The Canadian dollar nosed up 0.05 cents at 74.67 cents U.S. In company news, Mullen Group fell $1.05, or 6.7%, to $14.55 after the logistics provider said its revenue will reach $500 million although profit margins softened due to a slowdown in global trade and consumer spending. Colliers International Group gained $3.49, or 2.6%, to $136.35 after Scotiabank upgraded the stock to "outperform". Among health-care issues, Bausch Health Companies picked up 28 cents, or 2.8%, to $10.34, while Canopy Growth grabbed eight cents, or 2.3%, to $3.57. In tech stocks, HUT 8 Mining jumped 36 cents or 17%, to $2.48, while Absolute Software took on $1.12, or 7.5%, to $16.02. On the economic calendar, manufacturing sales in Canada were unchanged in November with higher sales in the motor vehicle and fabricated metal industries offset by lower sales in the chemical and petroleum and coal product industries, while the Canadian Real Estate Association reported national home sales rose 1.3% month-over-month in December.

Bausch Health Companies Inc. (NYSE:BHC) closed Wednesday at $7.31 per share, down from $7.48 a day earlier. While Bausch Health Companies Inc. has underperformed by -2.27%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BHC fell by -72.29%, with highs and lows ranging from $27.90 to […]

Equities in Toronto finished Monday, the penultimate session of January, on the downside, as losses in health-care cast a shadow over markets. The TSX fell 142.37 points to close Monday at 20,572.11. The Canadian dollar let go of 0.45 cents at 74.70 cents U.S. Health-care took the worst pounding, as Bausch Health lost 75 cents, or 6.7%, to $10.40, while Tilray handed over 14 cents, or 3.3%, to $4.14. In energy, Peyto Exploration wilted 79 cents, or 6.1%, to $12.23, while Nuvista dipped 52 cents, or 4.4%, to $11.19. Tech stocks also felt around for the bruises, mostly Quarterhill, down 10 cents, or 5.2%, to $1.84, while Shopify suffered $3.15, or 4.7%, to $63.51. Industrial stocks such as Ritchie Bros Auctioneers, progressed $1.22, or 1.6%, to $79.67. Brookfield Business Partners gained 31 cents, or 1.1%, to $27.88. Communications also made gains, primarily BCE, up 52 cents to $62.84 while Cogeco Communications added 47 cents to $69.26. Among individual stocks, Fairfax Financial Holdings climbed $15.96, or 1.9%, to $867.26 after BMO raised the insurer''s rating to "outperform" from "market perform".

On CNBC’s "Mad Money Lightning Round," Jim Cramer said L3Harris Technologies Inc (NYSE: LHX ) is still a buy. "There’s so many people betting against it, and they’re wrong," he added. Analysts have a consensus Neutral rating on LHX, according to Benzinga analyst ratings data. When asked about Bausch Health Companies Inc (NYSE: BHC ), he said, "We’ve got that on what I would regard as being a retainer basis. We simply don’t know … Full story available on Benzinga.com

Bausch Health Companies Inc. (NYSE:BHC) closed Thursday at $7.77 per share, down from $7.89 a day earlier. While Bausch Health Companies Inc. has underperformed by -1.52%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BHC fell by -70.79%, with highs and lows ranging from $26.88 to […]

Canada''s main stock index rose for a seventh consecutive session on Monday, lifted by energy, financial and technology stocks, while traders looked ahead to a week packed with key economic data including consumer price inflation. The TSX progressed 53.16 points to break for lunch at 20,413.26. The Canadian dollar nosed up 0.05 cents at 74.67 cents U.S. In company news, Mullen Group fell $1.05, or 6.7%, to $14.55 after the logistics provider said its revenue will reach $500 million although profit margins softened due to a slowdown in global trade and consumer spending. Colliers International Group gained $3.49, or 2.6%, to $136.35 after Scotiabank upgraded the stock to "outperform". Among health-care issues, Bausch Health Companies picked up 28 cents, or 2.8%, to $10.34, while Canopy Growth grabbed eight cents, or 2.3%, to $3.57. In tech stocks, HUT 8 Mining jumped 36 cents or 17%, to $2.48, while Absolute Software took on $1.12, or 7.5%, to $16.02. On the economic calendar, manufacturing sales in Canada were unchanged in November with higher sales in the motor vehicle and fabricated metal industries offset by lower sales in the chemical and petroleum and coal product industries, while the Canadian Real Estate Association reported national home sales rose 1.3% month-over-month in December.

Bausch Health Companies Inc. (NYSE:BHC) closed Wednesday at $7.31 per share, down from $7.48 a day earlier. While Bausch Health Companies Inc. has underperformed by -2.27%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BHC fell by -72.29%, with highs and lows ranging from $27.90 to […]

New York, USA, June 07, 2022 (GLOBE NEWSWIRE) -- The Global Medical Aesthetic Devices Market to Surpass USD 25 billion by 2027 | DelveInsight The medical aesthetic devices market is anticipated to expand due to an increase in the global ageing population. Moreover, shifting preferences toward minimally invasive or non-invasive cosmetic procedures could also bolster the demand for newly developed medical aesthetic devices in the upcoming years. According to the latest report published by DelveInsight, " Medical Aesthetic Devices Market Insight ," the global medical aesthetic devices market is likely to grow significantly due to an increase in various cosmetic procedures, either surgical or nonsurgical, globally. In addition, factors such as an increase in trauma injuries, different types of cancer requiring reconstructive surgeries following the treatment, a rise in obesity among the population, and growing technological advancement in the product arena are expected to add to the market growth.

DUBLIN , June 7, 2022 /PRNewswire/ -- The "Global Cosmetic Surgery and Procedure Market Size, Share & Industry Trends Analysis Report By Procedure Type, By Non-invasive Type, By Invasive Type, By Regional Outlook and Forecast, 2021-2027" report has been added to ResearchAndMarkets.com''s offering. The Global Cosmetic Surgery And Procedure Market size is expected to reach $107.2 billion by 2027, rising at a market growth of 9.8% CAGR during the forecast period. Cosmetic surgery is a specialized area of medicine that focuses on enhancing one''s look through surgical and medicinal methods. All sections of the head, neck, and body can benefit from cosmetic surgery. In addition, cosmetic surgery is opted by the people who want to increase the aesthetic appeal of a functional body part. The invention of new cosmetic devices through manufactures has resulted in an increase in demand for cosmetic therapies in recent years. The overview of technologically enhanced product lines, such as non-invasive body contouring systems that use fat freezing technology, for example, is expected to generate lucrative growth opportunities.

Las Vegas, USA, June 01, 2022 (GLOBE NEWSWIRE) -- The Global Eyewear Market is Expected to Reach Approximately USD 190 Billion by 2027, Estimates DelveInsight The stellar growth observed in the Eyewear market is primarily due to the increase in the prevalence of the population suffering from various vision impairments such as refractive errors, cataracts, and others, also, the development of eyewear with innovative designs have increased the popularity of different fashion eyewear among the millennials. DelveInsight''s Eyewear Market Insights and Forecast report provide the current and forecast Eyewear, upcoming innovations in the devices, individual market shares of the devices, challenges, drivers, and barriers, market trends, and key competitors in the Eyewear Market scenario. Some of the essential takeaways from the Eyewear Market report: According to DelveInsight analysis, North America is expected to dominate the overall Eyewear Market during the forecasted period. Key Eyewear companies proactively working in the market include Alcon, Inc., Johnson & Johnson, Inc., EssilorLuxottica, CooperVision (CooperCompanies), Bausch Health Companies Inc., SAFILO GROUP S.P.A., ZEISS International, Fielmann AG, JINS Eyewear US, Inc., LENSMAM CO., LTD., VIEWELL.INC, POLYTOUCH, SEED Co., Ltd., Menicon Co., Ltd., OPTEX AUSTRALIA, Sunshades Eyewear, HOYA Corporation, American Sunglass Manufacturing (AmSun Manufacturing Inc.), Charlie V, Eyeking, SightGlass Vision, Inc., and others.

NEW YORK , May 18, 2022 /PRNewswire/ -- The Parkinson''s disease (PD) drugs market size is expected to grow by USD 1.57 billion from 2019 to 2024 at a CAGR of 6% as per the latest market report by Technavio. 37% of the market''s growth will originate from Europe during the forecast period. Germany , Italy , the UK, and Spain are the key markets for Parkinson''s disease (PD) drugs in Europe . Market growth in this region will be faster than the market''s growth in the Asian and North American regions. The strong prevalence of PD and the easy availability of multiple approved drugs will facilitate the Parkinson''s disease (PD) drug market growth in Europe over the forecast period. For more insights on the market share of various regions - Download a sample report in MINUTES Read the 120-page report with TOC on "Parkinson''s Disease (PD) Drugs Market Analysis Report by D rug class (DA and levodopa-carbidopa, MAO inhibitors, AChE inhibitors, glutamate inhibitors, and others) and Geography ( Europe , North America , Asia , and ROW), and the Segment Forecasts,2020-2024".